BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33393495)

  • 1. Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas.
    Amoedo ND; Sarlak S; Obre E; Esteves P; Bégueret H; Kieffer Y; Rousseau B; Dupis A; Izotte J; Bellance N; Dard L; Redonnet-Vernhet I; Punzi G; Rodrigues MF; Dumon E; Mafhouf W; Guyonnet-Dupérat V; Gales L; Palama T; Bellvert F; Dugot-Senan N; Claverol S; Baste JM; Lacombe D; Rezvani HR; Pierri CL; Mechta-Grigoriou F; Thumerel M; Rossignol R
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mitochondrial trifunctional protein and its inactivation study for medicine development.
    Liu X; Wu L; Deng G; Li N; Chu X; Guo F; Li D
    Biochim Biophys Acta; 2008 Nov; 1784(11):1742-9. PubMed ID: 18640292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.
    Djouadi F; Habarou F; Le Bachelier C; Ferdinandusse S; Schlemmer D; Benoist JF; Boutron A; Andresen BS; Visser G; de Lonlay P; Olpin S; Fukao T; Yamaguchi S; Strauss AW; Wanders RJ; Bastin J
    J Inherit Metab Dis; 2016 Jan; 39(1):47-58. PubMed ID: 26109258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient with mitochondrial trifunctional protein deficiency due to the mutations in the HADHB gene showed recurrent myalgia since early childhood and was diagnosed in adolescence.
    Yagi M; Lee T; Awano H; Tsuji M; Tajima G; Kobayashi H; Hasegawa Y; Yamaguchi S; Takeshima Y; Matsuo M
    Mol Genet Metab; 2011 Dec; 104(4):556-9. PubMed ID: 22000755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
    Kantor PF; Lucien A; Kozak R; Lopaschuk GD
    Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.
    Yamamoto K; Abe S; Honda A; Hashimoto J; Aizawa Y; Ishibashi S; Takemura T; Hanagata N; Yamamoto M; Miura O; Kurata M; Kitagawa M
    Lab Invest; 2020 Mar; 100(3):353-362. PubMed ID: 31527828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport system.
    Hall A; Larsen AK; Parhamifar L; Meyle KD; Wu LP; Moghimi SM
    Biochim Biophys Acta; 2013 Oct; 1827(10):1213-25. PubMed ID: 23850549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HADHA and HADHB gene associated phenotypes - Identification of rare variants in a patient cohort by Next Generation Sequencing.
    Diebold I; Schön U; Horvath R; Schwartz O; Holinski-Feder E; Kölbel H; Abicht A
    Mol Cell Probes; 2019 Apr; 44():14-20. PubMed ID: 30682426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (Review).
    Wang X; Song H; Liang J; Jia Y; Zhang Y
    Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36239258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial β-oxidation enzyme HADHA.
    Thapa D; Wu K; Stoner MW; Xie B; Zhang M; Manning JR; Lu Z; Li JH; Chen Y; Gucek M; Playford MP; Mehta NN; Harmon D; O'Doherty RM; Jurczak MJ; Sack MN; Scott I
    J Biol Chem; 2018 Nov; 293(46):17676-17684. PubMed ID: 30323061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency.
    Boutron A; Acquaviva C; Vianey-Saban C; de Lonlay P; de Baulny HO; Guffon N; Dobbelaere D; Feillet F; Labarthe F; Lamireau D; Cano A; de Villemeur TB; Munnich A; Saudubray JM; Rabier D; Rigal O; Brivet M
    Mol Genet Metab; 2011 Aug; 103(4):341-8. PubMed ID: 21549624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression.
    Amako Y; Munakata T; Kohara M; Siddiqui A; Peers C; Harris M
    J Virol; 2015 Apr; 89(8):4092-101. PubMed ID: 25673715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Human Lung Adenocarcinoma with a Suppressor of Mitochondrial Superoxide Production.
    Dias Amoedo N; Dard L; Sarlak S; Mahfouf W; Blanchard W; Rousseau B; Izotte J; Claverol S; Lacombe D; Rezvani HR; Pierri CL; Rossignol R
    Antioxid Redox Signal; 2020 Nov; 33(13):883-902. PubMed ID: 32475148
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete deficiency of mitochondrial trifunctional protein due to a novel mutation within the beta-subunit of the mitochondrial trifunctional protein gene leads to failure of long-chain fatty acid beta-oxidation with fatal outcome.
    Schwab KO; Ensenauer R; Matern D; Uyanik G; Schnieders B; Wanders RA; Lehnert W
    Eur J Pediatr; 2003 Feb; 162(2):90-5. PubMed ID: 12548384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene.
    Das AM; Illsinger S; Lücke T; Hartmann H; Ruiter JP; Steuerwald U; Waterham HR; Duran M; Wanders RJ
    Clin Chem; 2006 Mar; 52(3):530-4. PubMed ID: 16423905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists.
    Andela VB; Altuwaijri S; Wood J; Rosier RN
    FEBS Lett; 2005 Mar; 579(7):1765-9. PubMed ID: 15757673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice.
    Al-Habsi M; Chamoto K; Matsumoto K; Nomura N; Zhang B; Sugiura Y; Sonomura K; Maharani A; Nakajima Y; Wu Y; Nomura Y; Menzies R; Tajima M; Kitaoka K; Haku Y; Delghandi S; Yurimoto K; Matsuda F; Iwata S; Ogura T; Fagarasan S; Honjo T
    Science; 2022 Oct; 378(6618):eabj3510. PubMed ID: 36302005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition.
    Trotta AP; Gelles JD; Serasinghe MN; Loi P; Arbiser JL; Chipuk JE
    J Biol Chem; 2017 Jul; 292(28):11727-11739. PubMed ID: 28546431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex.
    Wang Y; Palmfeldt J; Gregersen N; Makhov AM; Conway JF; Wang M; McCalley SP; Basu S; Alharbi H; St Croix C; Calderon MJ; Watkins S; Vockley J
    J Biol Chem; 2019 Aug; 294(33):12380-12391. PubMed ID: 31235473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
    Lopaschuk GD; Barr R; Thomas PD; Dyck JR
    Circ Res; 2003 Aug; 93(3):e33-7. PubMed ID: 12869392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.